Rchr
J-GLOBAL ID:202201017745678760   Update date: May. 26, 2024

Suzuki Rikio

スズキ リキオ | Suzuki Rikio
Affiliation and department:
Job title: Junior Associate Professor
Research field  (1): Hematology and oncology
Research theme for competitive and other funds  (2):
  • 2019 - 2022 Development of less invasive treatment for central nervous system invasion of refractory hematologic malignancies.
  • 2018 - 2022 Elucidation and overcoming of drug resistance mechanism mediated by semaphorin 3A signal in multiple myeloma
Papers (42):
  • Toshiro Seki, Rikio Suzuki, Shino Ohshima, Yoshiyuki Manabe, Shion Onoue, Yuki Hoshino, Atsushi Yasuda, Ryoji Ito, Hiroshi Kawada, Hitoshi Ishimoto, et al. Liposome-encapsulated progesterone efficiently suppresses B-lineage cell proliferation. Biochemistry and biophysics reports. 2024. 38. 101710-101710
  • Makoto Onizuka, Eri Kikkawa, Shinichiro Machida, Masako Toyosaki, Rikio Suzuki, Daisuke Ogiya, Yasuyuki Aoyama, Jun Amaki, Kaito Harada, Ryujiro Hara, et al. Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia. Blood cell therapy. 2023. 6. 3. 80-86
  • Daisuke Minakata, Tadao Ishida, Kiyoshi Ando, Rikio Suzuki, Junji Tanaka, Shotaro Hagiwara, Revathi Ananthakrishnan, Shigeki Kuwayama, Mitsufumi Nishio, Yoshinobu Kanda, et al. Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma. International journal of hematology. 2023. 117. 5. 729-737
  • Rikio Suzuki, Daisuke Ogiya, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando. Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma. Current oncology (Toronto, Ont.). 2022. 29. 11. 8529-8539
  • Sawako Shiraiwa, Kaito Harada, Makoto Onizuka, Shohei Kawakami, Ryujiro Hara, Yasuyuki Aoyama, Jun Amaki, Daisuke Ogiya, Rikio Suzuki, Masako Toyosaki, et al. Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2022. 28. 9. 1279-1285
more...
Work history (8):
  • 2024/04 - 現在 Tokai University Department of Hematology/Oncology Associate Professor
  • 2019/04 - 2024/03 Tokai University Department of Hematology/Oncology Lecturer
  • 2017/04 - 2019/03 Tokai University Department of Hematology/Oncology Assistant professor
  • 2015/04 - 2017/03 秦野赤十字病院 血液内科
  • 2014/10 - 2015/03 海老名総合病院 血液内科
Show all
Awards (4):
  • 2018 - 日本骨髄腫学会 平成30年度日本骨髄腫学会奨励賞
  • 2017 - 日本血液学会 日本血液学会平成29年度研究助成
  • 2013 - 2013 ASH Abstract Achievement Award
  • 2011 - 先進医薬研究振興財団 平成23年度血液医学分野海外留学助成
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page